Neurotransmitter CART as a New Therapeutic Candidate for Parkinson's Disease.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 1, p. 108, doi. 10.3390/ph6010108
- By:
- Publication type:
- Article
Works matching IS 14248247 AND DT 2013 AND VI 6 AND IP 1
Results: 7
1
2
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 1, p. 85, doi. 10.3390/ph6010085
- By:
- Publication type:
- Article
3
Clevidipine for Perioperative Blood Pressure Control in Infants and Children.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 1, p. 70, doi. 10.3390/ph6010070
- By:
- Publication type:
- Article
4
A Potent (R)-alpha-bis-lipoyl Derivative Containing 8-Hydroxyquinoline Scaffold: Synthesis and Biological Evaluation of Its Neuroprotective Capabilities in SH-SY5Y Human Neuroblastoma Cells.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 1, p. 54, doi. 10.3390/ph6010054
- By:
- Publication type:
- Article
5
The Potential Role of Cell Penetrating Peptides in the Intracellular Delivery of Proteins for Therapy of Erythroid Related Disorders.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 1, p. 32, doi. 10.3390/ph6010032
- By:
- Publication type:
- Article
6
Stability of Recombinant Tissue Plasminogen Activator at -30 °C over One Year.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 1, p. 25, doi. 10.3390/ph6010025
- By:
- Publication type:
- Article
7
Strategies To Modulate Heritable Epigenetic Defects in Cellular Machinery: Lessons from Nature.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 1, p. 1, doi. 10.3390/ph6010001
- By:
- Publication type:
- Article